Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ependymin related protein 1 pseudogene (ENSG00000271495) is a human genomic locus classified as a pseudogene, meaning it contains sequence homology to the functional ependymin related protein 1 (EPDR1) gene but is unable to produce a functional protein product due to disabling mutations or loss of coding potential[3][1][5]. This pseudogene is not known to code for any functional RNA or protein, is not considered a direct drug or therapeutic target, and has no established biomarker or disease role in the current literature. Like many pseudogenes, it is part of the “processed pseudogene” class, arising from retrotransposition events, but does not exert a known biological or clinical function in humans[7][1][2]. ENSG00000271495 is not a protein, not a therapeutic target, and instead represents a non-functional remnant of a gene (pseudogene) with no known clinical significance[3][1][5]. If detailed functional or disease role information were discovered in the future, this could change, but as of now, it is used primarily as a genomic annotation and is not relevant for drug discovery or biomarker research.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ependymin related protein 1 pseudogene.